Evaluation And Comparison Of Various Histopathological Assessment Systems In Breast Carcinoma Patients After Neoadjuvant Chemotherapy

dc.contributor.guideDr. Sunita Vagha
dc.coverage.spatial
dc.creator.researcherDr. Anita Sajjanar
dc.date.accessioned2026-02-12T12:29:26Z
dc.date.available2026-02-12T12:29:26Z
dc.date.awarded2026
dc.date.completed2026
dc.date.registered2020
dc.description.abstractnewline ABSTRACT newlineBackground: Breast carcinoma remains the most common malignancy among women worldwide, with a substantial proportion of patients in India presenting at a locally advanced stage. Neoadjuvant chemotherapy (NACT) has emerged as a standard therapeutic approach in such cases, offering tumour downstaging, increased breast conservation rates, and early assessment of chemosensitivity. Accurate histopathological evaluation of post-NACT specimens is critical for prognostication and therapeutic decision-making. However, multiple histopathological response assessment systems are currently in use, including Miller Payne, Residual Cancer Burden (RCB), AJCC ypTNM, Sataloff, Chevallier, Pinder, and NSABP B-18 systems, with no universal consensus regarding the most reliable and practical method. newlineAim: To evaluate and compare various histopathological assessment systems used for determining tumor response in breast carcinoma patients treated with neoadjuvant chemotherapy and to identify the system with the best prognostic performance and clinical applicability. newlineObjectives: newline1. To assess histopathological response to NACT using established grading systems. newline2. To correlate pathological response categories with clinicopathological and biomolecular parameters. newline3. To compare the prognostic accuracy and reproducibility of existing response assessment systems. newline4. To evaluate the performance of a proposed integrated reporting approach for post-NACT specimens. newlineMaterials and Methods: This observational study included breast carcinoma patients who received NACT followed by surgical resection. Pre-treatment core biopsy and post-NACT surgical specimens were evaluated histopathologically. Multiple response assessment systems Miller Payne, RCB, AJCC ypTNM, Sataloff, Chevallier, Pinder, and NSABP B-18 were applied to the same cohort. Clinicopathological variables including tumor size, histological type, grade, lymphovascular invasion, nodal status, and ER/PR/HER2 status were analyzed. Statistical analysis included chi-square
dc.description.note
dc.format.accompanyingmaterialDVD
dc.format.dimensions
dc.format.extent
dc.identifier.researcherid
dc.identifier.urihttp://hdl.handle.net/10603/695088
dc.languageEnglish
dc.publisher.institutionFaculty of Medicine
dc.publisher.placeWardha
dc.publisher.universityDatta Meghe Institute of Medical Sciences
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordClinical Medicine
dc.subject.keywordPathology
dc.titleEvaluation And Comparison Of Various Histopathological Assessment Systems In Breast Carcinoma Patients After Neoadjuvant Chemotherapy
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 12
Loading...
Thumbnail Image
Name:
80_recommendation.pdf
Size:
288.09 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
abstract .pdf
Size:
113.7 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
annexures.pdf
Size:
1.11 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
chapter 1.pdf
Size:
384.19 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
chapter 2.pdf
Size:
581.43 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: